These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16446851)

  • 21. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum chitotriosidase activity in acute coronary syndrome.
    Yildiz BS; Barutcuoglu B; Alihanoglu YI; Alkan MB; Bilgin M; Gul I; Gungor H; Esin F; Sayin A; Zoghi M
    J Atheroscler Thromb; 2013; 20(2):134-41. PubMed ID: 22986554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ST-segment elevation in lead aVR in the setting of acute coronary syndrome.
    Nabati M; Emadi M; Mollaalipour M; Bagheri B; Nouraei M
    Acta Cardiol; 2016 Feb; 71(1):47-54. PubMed ID: 26853253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants].
    Bodí V; Facila L; Sanchis J; Llácer A; Núñez J; Mainar L; Gómez-Aldaraví R; Monmeneu JV; Blasco ML; Sanjuan R; Insa L; Chorro FJ
    Rev Esp Cardiol; 2002 Aug; 55(8):823-30. PubMed ID: 12199978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative cardiac troponin I in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
    Thielmann M; Massoudy P; Neuhäuser M; Knipp S; Kamler M; Piotrowski J; Mann K; Jakob H
    Chest; 2005 Nov; 128(5):3526-36. PubMed ID: 16304309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.
    Matsui S; Ishii J; Kitagawa F; Kuno A; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Tanaka I; Nomura M; Hishida H; Ozaki Y
    Atherosclerosis; 2010 May; 210(1):220-5. PubMed ID: 19945702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.
    Kaski JC; Consuegra-Sanchez L; Fernandez-Berges DJ; Cruz-Fernandez JM; Garcia-Moll X; Marrugat J; Mostaza J; Toro-Cebada R; González-Juanatey JR; Guzmán-Martínez G;
    Atherosclerosis; 2008 Nov; 201(1):176-83. PubMed ID: 18336825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
    Sanchez PL; Morinigo JL; Pabon P; Martin F; Piedra I; Palacios IF; Martin-Luengo C
    Heart; 2004 Mar; 90(3):264-9. PubMed ID: 14966041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Qualitative determination of markers for myocardiac necrosis during pre-hospital admission for acute coronary syndrome].
    Borrayo-Sánchez G; Sosa-Jarero F; Borja-Terán B; Isordia-Salas I; Argüero-Sánchez R
    Cir Cir; 2006; 74(4):231-5. PubMed ID: 17022893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammation markers and risk stratification in patients with acute coronary syndromes: design of the SIESTA Study (Systemic Inflammation Evaluation in Patients with non-ST segment elevation Acute coronary syndromes)].
    Kaski JC; Cruz-Fernández JM; Fernández-Bergés D; García-Moll X; Martín Jadraque L; Mostaza J; López García-Aranda V; González Juanatey JR; Castro Beiras A; Martín Luengo C; Alonso García A; López-Bescós L; Marcos Gómez G;
    Rev Esp Cardiol; 2003 Apr; 56(4):389-95. PubMed ID: 12689574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Six-month outcomes and prediction of mortality in 458 patients with acute coronary syndromes without persistent ST segment elevation assigned to early invasive strategy].
    Szyguła-Jurkiewicz B; Wilczek K; Zembala M; Mercik G; Poloński L
    Pol Arch Med Wewn; 2004 Dec; 112(6):1459-66. PubMed ID: 15962611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes.
    Zha Y; Chen Y; Xu F; Li T; Zhao C; Cui L
    Biomed Pharmacother; 2010 Mar; 64(3):160-4. PubMed ID: 19944557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events.
    Dogan A; Icli A; Aksoy F; Varol E; Erdogan D; Ozaydin M; Kocyigit S
    Coron Artery Dis; 2012 Jan; 23(1):39-44. PubMed ID: 22107801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
    Oltrona L; Ottani F; Galvani M;
    Am Heart J; 2004 Sep; 148(3):405-15. PubMed ID: 15389226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.